IVONNE FRADY: Open Payments
NPI 1811322944 · SUNRISE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$848 in 34 payments from 12 companies in 2025. Trend: 2023 $178 · 2024 $279 · 2025 $848
Food & beverage: $848
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $248 |
| Ardelyx, Inc. | 6 | $138 |
| Madrigal Pharmaceuticals | 3 | $86 |
| GENZYME CORPORATION | 2 | $73 |
| ABBVIE INC. | 3 | $60 |
| Aimmune Therapeutics, Inc. | 3 | $59 |
| Lilly USA, LLC | 2 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Braintree Laboratories, Inc. | 1 | $29 |
| Intercept Pharmaceuticals, Inc. | 1 | $24 |
Products named: TREMFYA, IBSRELA, REZDIFFRA, DUPIXENT, ZENPEP, OMVOH, LINZESS, ENTYVIO.
Industry payments across FL — which companies pay providers there.
